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Every organism has armed itself with the immune system for the protection 
against the infection of various pathogens. The host tried to recognize and to 
distinguish non-self organism for the initiation of protective immunity. The 
representative innate sensor is Interleukin 1 receptor (IL-1R)/ Toll-like receptor 
(TLR) superfamily whish is primitive signal for the induction of immune responses 
when the host is infected with various pathogens. In this study, I aimed to clarify 
the role of innate signal in the protective immunity against bacterial infection. 
In the first part of this study, interleukin (IL)-1 is a well-known cytokine for 
the initiation of innate immunity together with TNF- in bacterial infection. 
However, the underlying mechanism of IL-1 on the respiratory infection is not 
fully elucidated. It was studied how IL-1 signal contributes to the host defense 
pathway against Streptococcus (S.) pneumoniae in a mouse model. IL-1R
-/-
 mice 
showed high mortality, local cytokine storm, and substantial infiltrates in the lower 
respiratory tract after intratracheal challenge with S. pneumoniae. The IL-1-
ii 
 
deficient condition did not suppress the propagation of bacteria in the lung, 







) were not defective compared with wild-type mice. 
Unexpectedly, it was found that the transcription of fibrinogen alpha and gamma 
genes were highly activated in the lungs of wild-type mice after S. pneumoniae 
infection while no significant changes were found in IL-1R
-/-
 mice. Of note, 
synthesis of fibrinogen, which is crucial for clotting, in the lung in S. pneumoniae 
infection, was dependent on the IL-1-IL-6-Stat3 cascade. Treatment with 
recombinant fibrinogen improved survival and bacterial propagation in the IL-1R
-/-
 
mice and blockade of the coagulation pathway increased the susceptibility of wild-
type mice to pneumococcal pneumonia. These findings suggest that IL-1 signaling 
leads to the synthesis of fibrinogen in the lung after S. pneumoniae infection and is 
followed by coagulation, which contributes to the control of bacterial infection in 
the pulmonary tract. 
For the second part, the role of TLR signaling to link innate and adaptive 
immune systems has been one of controversial issues remained to be resolved. 
Here, it was determined whether MyD88-dependent TLR signals are required for 
the generation of B-cell responses during chronic Salmonella infection. Oral 
administration of recombinant attenuated Salmonella Typhimurium vaccine 
(RASV) strain in MyD88
-/-
 mice resulted in chronic infection. Infection was 
accompanied by enlarged germinal centers and hypergammaglobulinemia with 
anti-double-stranded DNA (dsDNA)-specific Ab in sera, and the deposition of 
immune complexes in the kidneys, suggesting onset of autoimmunity. CD4
+
 T cells 
expressing PD-1, CXCR5, ICOS, and IL-21 were dramatically increased in 
chronically-infected mice, indicating the expansion of follicular helper T (Tfh)-like 
cells. Of note, the depletion of CD4
+
 T cells completely blocked the generation of 
polyclonal IgG Ab in sera after oral RASV challenge. Inflammatory myeloid cells 





 mice. Interestingly, the blockade of PD-1 or ICOS significantly reduced the 
hypergammaglobulinemia and dsDNA-specific autoantibody production. Overall, 
these results suggest that Tfh-like cells in chronic bacterial infection trigger 
autoimmune hypergammaglobulinemia in a PD-1- and ICOS-dependent manner.  
 
Keywords: IL-1, S. pneumoniae, pneumonia, innate immunity, coagulation, 
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I. Bacterial pathogenesis 
1. Streptococcus pneumoniae 
Streptococcus pneumoniae (S. pneumoniae) is a gram-positive, anaerobic bacterium. 
It is the common cause of bacterial pneumonia and bacterial meningitis [1]. Pneumococci 
consist of diverse serotype. Some of them are invasive and others are not [2]. The other 
strains employ the phase variation. They are usually colonized in nasopharynx of healthy 
people as commensal bacteria. When the hosts are in the immunocompromised status 
such as virus infection, they secrete more capsular components and invade into lower 
respiratory tract [3]. 
The pneumococcus can easily colonize in the nose. One third of children have one 
serotype of pneumococcus. Also they are detectable in over 10% of the population 
including healthy adults who can act as a carrier to spread the bacteria in the community. 
Therefore the pneumococcus is classified as a community-acquired bacterium [4, 5]. 
Healthy hosts easily clear S. pneumoniae and they only experienced runny nose and 
sniffing. But unhealthy or certain condition such as baby, old, aging, AIDS. Cancer 
therapy can make this pathogen virulent and they can invade into the low respiratory tract 
such as lung [4, 6].  
The hosts have the machinery to recognize the pneumococcus. One of the well-
known pattern recognition receptors (PRRs) is the toll-like receptors (TLRs). TLR2 
binds to bacterial cell wall. TLR4 can detect the pneumolysin which bursts by autolysis 
of bacteria and attaches the host cell membrane to form the pore. TLR9 also has 
important role on detection of the infection by recognition of bacterial DNA [7]. These 




factor 88 (MyD88). MyD88 signal activates NFB and initiates the inflammation [8] 
(Fig. 1).  
In the inflammation against to pneumococci, there are crucial cells which are 
alveolar macrophage and neutrophils. Alveolar macrophages are tissue resident 
macrophages and they recognize the bacteria at the initiatory stage and kill them by 
phagocytosis [9]. Neutrophils are subsequently recruited into the lung. They are major 
phagocytes to clear the pneumococci [10]. 
 
2. Salmonella Typhi (-murium) 
Salmonella Typhi (-murium) is Gram-negative intracellular bacteria. It is the cause 
of typhoid fever. It is very common in the developing countries. It causes an epidemic 
because contaminated water can inflict illness to those who drink this water. 
Epidemiologist calculated the typhoid fever occurred over 21 million illnesses and 
216,510 deaths in 2000[11]. Salmonella Typhi is restricted to human. For animal study, 
Salmonella Typhimurium strain was discovered and it is an adaptive strain for mice and 
has similar pathogenesis to Salmonella Typhi in human. They invade from intestinal 
rumen to the host through M cells which are abundant in Peyer’s patches (PP) and also 
located in solitary intestinal lymphoid tissues on the intestinal epithelia using type III/IV 
secretion system [12, 13]. Then they move to mesenteric lymph node (MLN), which is 
the draining lymph node for the intestine, as freely by itself or with DC containing 
bacteria. They spread systemically to spleen, liver or kidney. Thus the major features in 
salmonellosis are fever and splenomegaly [14]. The infected host can induce immune 
responses sensing bacterial components. TLR-2, -4, -5, -9 recognized lipoprotein, 
lipopolysaccharide (LPS), flagellin and bacterial DNA, respectively [8]. In addition, S. 




Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and NOD2, 
which can recognize the bacterial components such as peptidoglycan [15] (Fig. 2). 
 
II. IL-1R/TLR superfamily 
1. IL-1R/TLR superfamily 
The term of “Interleukin-1 receptor (IL-1R)/ Toll-like receptor (TLR) superfamily” 
was defined in 1998 [16]. Both IL-1Rs and TLRs have an important role in the innate 
immunity. They are different of extracellular domains. IL-1R family has three 
immunoglobulin domains in the extracellular part. TLR family has leucine-rich repeats 
(LRRs). However, both receptor families have homologous cytosolic domain which is 
Toll/IL-1 Receptor (TIR) domain [16]. Furthermore, IL-1R and TLRs except TLR3 share 
the signaling adaptor molecule, which is myeloid differentiation factor 88 (MyD88) [17]. 
Therefore, the signal transduction of both receptors activate nuclear factor-B (NFB) 
through IL-1 receptor-associated kinase 4 (IRAK4) and IRAK1 [18]. Finally, NFB 
induce the expression of numerous genes for the initiation of inflammation-associated 
genes (Fig. 3). 
 
2. IL-1 and IL-1 receptor family 
IL-1 was first isolated about thirty years ago from macrophages [19]. It has been 
studied as the initiative factor for inflammation. Recently, IL-1 arose as a hot issue in the 
immunology field followed by the discovery of inflammasome, which is a machinery to 
transform the inactive form of pro-IL-1 to active form of IL-1 and IL-18 also [20]. 
There are two forms of IL-1, IL-1 and IL-1, which share the receptor and activities 
[21]. IL-1 is produced mainly by macrophages and by other myeloid cells. However, it 




heterodimeric receptor consisted of type I IL-1 receptor (IL-1RI) and IL-1 receptor 
accessory protein (IL-1RAcP) [21, 22]. There are other cytokines which are homologous 
to IL-1, IL-18 and IL-33. IL-18 and IL-33 are recognized by IL-1R-like receptors, IL-18 
receptor and IL-1 receptor-related protein-2 (IL-1Rrp2; which is also known as T1/ST2), 
respectively (Fig. 3) [23]. The roles of IL-18 and IL-33 are different from IL-1. IL-18 is 
important in cell-mediated immunity like Th1 type immunity [24]. And IL-33 is known 
as Th2 type immunity for B cell responses [25]. 
 
3. TLR and MyD88 
For recent several decades, immunologists were concerned about how the pathogens 
can be recognized separating the host cells. Someone looked for the bacterial specific 
sensory machinery to identify pathogen-associated molecular pattern (PAMP). Others 
insisted the host derived danger signals which emitted by damaged host cells. The 
various sensors, also called as pattern recognition receptors (PRRs) are discovered. Toll-
like receptor family (TLR) is the most well-defined PRR. 
TLR2 is a key receptor to recognize the bacterial cell wall which is first combined 
with CD14 [26]. TLR2 acts as homodimer or heterodimer together with TLR1 or TLR6. 
TLR4 is homodimeric receptor specific to LPS. TLR5 is a plasma membrane receptor 
and specific to flagellin [8]. There are endosomal receptors that are TLR3, 7(8) and 9 
[27]. These endosomal TLRs recognize bacterial or viral amino acids such as viral 
dsRNA, viral ssRNA and CpG DNA, respectively. MyD88 is a common adaptor 
molecule for TLRs except TLR3. TLR3 has TIR-domain-containing adapter-inducing 
interferon-β (TRIF) as an adaptor molecule. TLR4 has both adaptor molecules MyD88 






III. Helper T cell 
1. Subsets of helper T cell 
 T cell lineage is classified according to the type of T cell receptor (TCR). For 
instance, T cells have a heterodimeric receptor which consists of  and  chain. 
Likewise,  and  chain makeT cells. The T cells are categorized by the expression 
of CD4 or CD8 that are co-receptors for major histocompatibility complex (MHC) 
molecules. CD4
+
 T cells are named helper T cells (Th) because they help other type of 
cells such as B cells. Naïve Th cells are activated and progress clonal expansion when 
they encounter DC presenting peptide MHC class II complex which binds to T cell 
receptor (TCR). Activated Th cells are differentiated into various subsets which are 
determined by costimulatory molecules and cytokines from antigen presenting cells 
(APCs). Type I helper T cells (Th1) are developed by IL-12 and IFN-. The transcription 
factor, T-bet leads Th1 to produce IFN- for helping protective immunity against 
intracellular pathogen [28, 29]. Type II helper T cells (Th2) are induced by the Th2 
master regulator GATA-3. Th2 cells secrete IL-4, IL-5, IL-13 and support B cells to 
produce antibodies for extracellular pathogens [30]. The master regulators T-bet for Th1 
and GATA-3 for Th2 inhibit reciprocally to solidify the direction of development [31]. 
Th17 is recently defined as a subset of Th cells [32]. Th17 is termed according to the 
production of IL-17. TGF- and IL-6 induce the differentiation of Th17. Particularly, IL-
6 promotes RORt which is distinct transcription factor for Th17 [33]. For immune 
homeostasis, the initiation of inflammation is not only important, but the regulation of 
immune responses is also necessary. Regulatory T cells (Treg) exist to suppress other 
effector cells by inhibitory molecules and the production of IL-10. Treg cells are 
generated by TGF- signal. The characteristic transcription factor of Treg is Foxp3 





2. Follicular helper T cell 
Follicular helper T cell (Tfh) is a recently defined subset of helper T cell lineage [36]. 
The distinctive character of Tfh is its location in B cell region, not in extrafollicular T 
cell region. The translocation of Tfh is responsive to CXCL13, which is abundant in B 
cell follicles, through the expression of CXCR5 that is the receptor for CXCL13 and 
expressed on B cells and Tfh cells [31, 37]. The development of antigen-specific Tfh is 
strongly dependent on IL-6 and IL-21. IL-6 is able to produce IL-21through Stat3 in Th 
cells [38]. Induced IL-21 acts as an autocrine way to enhance the differentiation of naïve 
Th cells to Tfh [39, 40]. The distinguishable transcription factor of Tfh from other Th 
cell lineage such as Th1, Th2, Th17 and Treg is bcl-6 [41]. The function of Tfh is 
primarily to help B cell immunity for production of antibodies. For cognate interaction 
with B cells, Tfh cells express ICOS, OX40 and PD-1 on their surface. Those molecules 
bind to ICOSL, OX40L and PD-1L on B cells, respectively [42-45]. In addition, there are 
a number of evidences that Tfh is indispensable to germinal center formation. The 
inhibition of Tfh decreased the number of B cell follicles and germinal centers (Fig. 4) 
[31, 46, 47]. 
 
IV. Coagulation vs bacteria 
1. Host 
Coagulation system primarily exists to prevent of leakage of blood when injury of 
blood vessels occurs. Several factors from factor I to factor XII and tissue factor are 
associated in clotting formation. Those factors finally activate prothrombinase complex 
which cleaves the active form of thrombin. Thrombin acts as enzyme to cleave 
fibrinogen to make fibrin [48]. Coagulation does not involve in blood clotting only, but 
in the immune system also. Fibrin networks in the clot can entrap bacteria to prevent the 




inflammatory response. It is able to alter leukocyte functions, including cell adhesion, 
migration, and cytokine expression [48]. Mice lacking the fibrinogen binding motif 
(M2/Mac-1) have severely compromised inflammatory responses to bacterial infection 
that is by caused by their inability to inhibit the binding of leukocytes to fibrinogen [50]. 
Further, the formation of complexes between fibrinogen and bacteria activate neutrophil 
recruitment, which may induce vascular leakage [51]. 
 
2. Bacteria 
As the host has equipped itself with defense system against pathogens, bacteria too 
have developed means to circumvent host immunity. Group A Streptococcus (GAS) is 
known to have various weapons to escape host clotting [48]. For example, streptokinase 
produced by streptococcus activates plasminogen, which transforms to plasmin for 
fibrinolysis [52, 53]. Further, the M protein produced by GAS forms complexes with the 
host fibrinogen enabling resistance to phagocytosis [54]. Other bacteria, including 
Staphylococcus aureus and E. coli, also can escape the host coagulation system by using 
staphylokinase or flagella, respectively [55, 56]. However, S. pneumoniae has not been 
reported to avoid blood clotting despite its phylogenetic similarity to GAS and S. aureus. 
The efficacy of coagulation is thought to be pathogen-dependent and the murine 
pneumococcal pneumonia model is ideal for studying the relationship between bacteria 











Figure 1. Bacterial cell wall components (e.g. lipoproteins) and pneumolysin of 
Streptococcus pneumoniae are recognized by TLR2 and TLR4, respectively. The 
activated TLR signals through the adaptor molecules, MyD88 or TRIF.  The signaling 
pathways activate NFB and translocation of NFB into the nucleus NFB acts as a 
transcription factor for pro-inflammatory genes including IL-1. IL-1 signaling also 
conducts the activation of NFB. Produced inflammatory cytokines recruit neutrophils 







Figure 2. Salmonella invades by M cells in the gut. Several components of Salmonella 
bind to TLRs and other pattern recognition receptors (PRRs) such as NOD. Those PRRs 
induce pro-inflammatory cytokines. Dendritic cells (DCs) encountered Salmonella move 
to secondary lymph nodes and then create acquired immunity by presenting antigen to T 











Figure 3. TLRs and IL-1R families have TIR domain in intracellular compartment of 
those receptors. MyD88 is a universal adaptor molecule of the IL-1R/TLR superfamily. 
MyD88 delivers the signal to activate NFB. Active form of NFB moves to nucleus and 











Figure 4. Tfh cells are differentiated by the cytokines (IL-6 and IL-21) and 
transcriptional repressor (bcl-6). The hallmarks of Tfh are the expression of CXCR5,  
PD-1, ICOS and OX40 and the loss of CD127. Tfh also secretes IL-21. Those features 
















A normal person experiences numerous pathogens such as viruses, bacteria, fungi 
and parasites in his life. The host combats these invaders to keep sanitary and to protect 
the cells and tissues from destruction. Primary factors to overcome the infection are 
mechanisms to sense the pathogens. Toll-like receptor (TLR) is a representative receptor 
family in the series of pattern recognition receptors (PRRs). Thirteen different TLRs are 
reported currently in human and mouse. TLRs consisting of homodimer or heterodimer 
recognize various pathogen-associated molecular patterns (PAMPs). TLR signaling 
except TLR3 mainly conducts the universal adaptor molecule; Myeloid differentiation 
factor 88 (MyD88). The signals by MyD88 express inflammatory genes dependent on 
NFB as a transcription factor. TNF- and IL-1 are regarded as initiative cytokines for 
induction of inflammation. One of them, IL-1 signal, also accompanies MyD88 same as 
TLR signals. Therefore, IL-1 signal seems to mimic TLR signals to alert other cells that 
did not encounter pathogen. In the chapter I, the role of IL-1 signal for the protective 
immunity is clarified in the pulmonary infection with Streptococcus pneumoniae. 
Especially the highly conserved and primitive coagulation pathway is proposed to be a 
new member of innate immune responses in the bacterial pneumonia. 
Innate and adaptive immune responses are defined separately by several features 
such as responsive time, participating cells and their products. However, they are 
certainly connected bidirectionally in some aspects. The sensory machineries in innate 
immunity are important to activate antigen presenting cells (APC) such as dendritic cells 
(DC). In reverse, Th17 cells play a role in the recruitment of neutrophils which are 




complement system which is called as classical pathway. In the chapter II, another 
possibility is suggested in which chronic infection of salmonella in the innate immune-
deficient condition can affect the fate of adaptive immune responses. Additionally, the 
follicular helper T cell (Tfh) is implied as the underlying mechanism of autoantibody 






































Interleukin-1 promotes coagulation which is 
necessary for protective immunity in the lung 












 Streptococcus pneumoniae, a gram-positive anaerobic bacterium, is arguably the most 
common cause of pneumonia in the world. It has been described as “the captain of all 
the men of death” [6, 57]. Colonization with pneumococcus typically induces mild 
symptoms that are easily cleared in healthy people; however, when risk factors weaken 
the protective immunity (e.g., the patient’s age, diabetes, and HIV infection) 
pneumococcus can cause serious diseases [6]. Pneumococcal pneumonia frequently 
arises after infection by a secondary pathogen such as influenza [58]. For instance, 
more than half of those who died during the 1918 Spanish flu pandemic (H1N1 
influenza A) died after of secondary infection with pneumococcus [59]. Moreover, the 
more recent emergence of antibiotic-resistant pneumococci, termed ‘superbacteria’, 
makes patient treatment more difficult [60]. Therefore, alternative therapies are needed 
to enhance the immune system.  
  The recognition of S. pneumoniae by the host is mediated by various ways. For 
instance, pattern recognition receptors such as toll-like receptors (TLRs) are expressed 
on airway epithelia and alveolar macrophages [8]. The bacterial cell wall component is 
recognized by TLR2 and the pneumococcal toxin pneumolysin depends on TLR4 [61]. 
These TLRs trigger the activation of NFB which, in turn, mediates the signaling 
pathways from IL-1 and the TNF receptor super families [8]. The nuclear translocation 
of NFB is sufficient for the recruitment of neutrophils that are crucial for the clearance 
of pneumococcus [62]. In addition, natural IgM antibodies bind to the bacterial surface 
and increase resistance to pneumococcal pneumonia [57]. 
  Coagulation systems are important for innate immunity in invertebrates and 
vertebrates ranging from drosophila to humans [49]. Fibrinogen, the source of clot 
formation, is synthesized in the liver and circulates in blood vessels in the natural state 




is the early innate response to bacterial infection and that bacteria are trapped and killed 
by fibrin formation [49, 64]. Thus, regulation of the coagulation system has become a 
topic of interest in regard to host response to bacterial infection. However, the 
contribution of coagulation in other tissues such as lung has been poorly established. 
  Here is shown that IL-1 receptor-mediated signal plays an indispensable role in 
protection against pneumococcal pneumonia. Unexpectedly, fibrinogen synthesis in the 
lung after S. pneumoniae infection was significantly down-regulated in IL-1R
-/-
 mice, 
unlike findings in wild-type mice. Moreover, the inhibition of coagulation in wild-type 
mice increased their mortality and bacterial burden. In vivo intratracheal treatment with 
mouse fibrinogen reinstated the susceptibility of IL-1R
-/-
 mice to S. pneumoniae 
infection. Overall, these findings imply that IL-1 signal can activate fibrinogen 
synthesis in the lung and that coagulation is an important mechanism for protection 





II. Materials and Methods 
 
1. Ethics Statement 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee of the International Vaccine Institute (Approval No: PN 2010-003), and 
all experiments were carried out in strict accordance with the Guide for the Care 
and Use of Laboratory Animals, Institute of Laboratory Animal Resources 
Commission on Life Sciences National Research Council, USA. All experiments 
were performed under anesthesia with a mixture of ketamine (100 mg/kg) and 
xylazine (20 mg/kg), and all efforts were made to minimize suffering. 
 
2. Mice  
Wild-type C57BL/6 (B6) and IL-1R
-/-
 mice were purchased from Charles River 
Laboratories (Orient Bio, Inc., Korea) and Jackson Laboratories (Bar Harbor, ME), 
respectively. All mice used in experiments were between 6 and 12 weeks of age. 
Mice were maintained under pathogen-free conditions in the experimental facility 
at the International Vaccine Institute (Seoul, Korea), where they received sterilized 
food and water ad libitum. The experiments were approved by the Institutional 
Animal Care and Use Committee of the International Vaccine Institute.  
 
3. Bacteria strain and infection 
S. pneumoniae virulent capsular serotype 3 strain WU2 was cloned on trypticase 
soy agar containing 5% sheep blood (BD Biosciences, San Jose, CA) and cultured 
in Todd-Hewitt broth (BD Biosciences) plus 0.5% yeast extract (THY medium, BD 
Biosciences). WU2 strain was grown in 50 ml of THY medium until O.D.=0.4, 
adjusted with 15% glycerol, and frozen in 1-ml aliquots. For inoculation, a fresh 




forming units (CFU) injected was confirmed by plating on 5% sheep blood (BD 
Biosciences) as described previously [65]. After mice were anesthetized, they were 
given 5 × 10
5
 colony-forming units (CFU) or 5 × 10
3
 CFU/30 l of S. pneumoniae 
diluted in PBS intranasally. All bacteria used in this study, WU2 strain, wild-type S. 
pneumoniae TIGR4 strain (AC535), and the mutant strain (AC1142) attenuated by 
suppression of tryptophan biosynthesis were kindly provided by Prof. David Briles 
(Department of Microbiology, Univ. of Alabama at Birmingham, USA) [66].  
 
4. Treatment in vivo 
Six hours after the IL-1R
-/-
 mice were infected with WU2 (5x10
5
 CFU), they were 
injected intraperitoneally (i.p.) with penicillin (1 mg/mouse). For the blockade of 
IL-6 signal, wild-type B6 mice were treated i.t. with PBS, anti-IL-6Ra antibody 
(Ab) (0.1 mg/mouse), or NSC 74859 (10 g/mouse; SellecBio.com, Houston, TX). 
Anti-IL-6Ra Ab was kindly provided by Prof. Tadamitsu Kishimoto (Osaka Univ., 
Japan). For the regulation of clotting cascade, IL-1R
-/-
 mice were treated i.t. with 
PBS or mouse fibrinogen (0.1 mg/mouse; Haematologic Technologies, Inc., Essex 
Junction, VT) at 0 and 1 day post-infection (dpi). Warfarin (10 g/mouse; DAE 
HWA Pharmaceutical Co., Ltd., Korea) was administered orally to wild-type B6 
mice every day beginning 1 day before infection.  
 
5. Preparation of bronchoalveolar lavage fluid (BALF) 
To obtain BALF, tracheas were cannulated after exsanguination and lungs were 
washed twice with 0.5 ml of PBS. BALF samples were centrifuged (800g, 5 min) 
to isolate cells and supernatant was centrifuged again (13,000g, 1 min) to 






6. Cytokine and fibrinogen detection 
The levels of MCP-1, IL-6, TNF-, and IFN- were determined by BD™ 
Cytometric Bead Array Mouse Inflammation Kit (BD Biosciences). The levels of 
KC and IL-6 were measured by DuoSet Mouse ELISA Kit (R&D Systems, 
Minneapolis, MN) and ELISA MAX™ Standard Sets (Biolegend, Inc., San Diego, 
CA), respectively. The mouse fibrinogen was quantified by Mouse Fibrinogen 
ELISA (Immunology Consultants Laboratory, Inc., Newberg, OR). All experiments 
were performed according to each manufacturer’s instructions. 
 
7. Histology 
The lungs were removed and washed in PBS before being fixed with 4% 
formaldehyde. The tissues were embedded in paraffin and stained with 
hematoxylin and eosin (H&E). Histopathological score was assessed by a 
pathologist using a blind test as previously described [68]. A 20-point scoring 
system was used to evaluate the level of lung tissue destruction, epithelial cell layer 
damage, polymorphonuclear (PMN) cell infiltration into the site, and alveolitis. For 
a confocal microscopy study, bacteria were stained with PKH26 Red Fluorescent 
General Cell Linker Kit (Sigma, St. Louis, MO) before infection according to the 
manufacturer’s instructions. Lungs were embedded in OCT compound (Sakura 
Finetec, Tokyo, Japan). Cryo sections (5 m) were fixed in ice-cold acetone. 
 
8. Determination of bacterial load 
Lungs were removed and homogenized in 1 ml of 0.2% Triton X-100 in PBS. 
Samples were serially diluted in PBS and plated onto TSA II™ (BD Biosciences, 





9. Flow cytometry 
Cells were collected from the BALF and stained with CD11b (M1/70), Ly6C (AL-
21), and Ly6G (1A8), which were purchased from BD Biosciences. 
 
10. Neutrophil killing assay in vitro 
To determine the neutrophil killing ability in vitro, the experiment was performed 
as previously described [69]. Peritoneal cells were obtained by peritoneal wash 
with 10 ml of 2% FBS-RPMI medium at 4.5 hr following i.p. injection with 2 ml of 
3% Brewer thioglycollate medium (Sigma-Aldrich, St. Louis, MO). The Ly6G
+
 
peritoneal neutrophils were purified by MACS (Miltenyi Biotec, Bergisch 
Gladbach, Germany) and resuspended in 2% FBS-RPMI medium. For negative 
control, sorted neutrophils  ere heat- i  ed at     C for 30 min. S. pneumoniae were 
resuspended in 2% FBS-RPMI medium and then added to a siliconized plate 
containing suspended neutrophils at a multiplicity of infection of 0.1 bacteria per 
cell. An aliquot of each well (25 µl) was diluted and immediately plated on TSA 
II™ (BD Biosciences) for counting (time = 0). The plate was placed under rotation 
at 37°C, and 25-µl aliquots were diluted and plated at each time point. 
 
11. Microarray analysis 
Whole lung tissues from B6 and IL-1R
-/-
 mice were obtained 4 hr post-infection 
after perfusion. The lungs were then homogenized and RNA was extracted (RNA 
Isolation Kit, Qiagen, Valencia, CA). The cDNA microarray analysis was 








12. Real-Time RT-PCR 
Total RNA was isolated from the whole lung. Reverse transcription was performed 
using SuperScript™ II Reverse Transcriptase (Invitrogen, Grand Island, NY) 
according to the manufacturer’s instructions. For rea -time PCR analysis, the 
cDNA was serially diluted 10-fold and amplified using the 7500 Real Time PCR 
System (Applied Biosystems, Grand Island, NY) with Power SYBR®  Green PCR 
Master Mix (Applied Biosystems). After the first denaturation step (95°C for 10 
min), amplification was performed for 40 cycles at 95°C for 15 s, 55°C for 15 s, 
and 72°C for 40 s. The final cycle was followed by the dissociation stage. The 
following primers were used: Fga— (forward) ACC AGG AGA CTC GCG GGG 
AG and (reverse) CCG TGG TCC CAG GGT TCC GA and Fgg—(forward) ACC 
TGT CGC CTA CTG GCA CCA and (reverse) TCG AAG GCA TCC CCG GCA 
TCT. 
 
13. Thrombin activity 
Thrombin activity in BALF collected from wild-type B6 or IL-1R
-/-
 mice at 0 or 1 
dpi was determined by SensoLyte
®
 AFC Thrombin Activity Assay Kit (AnaSpec, 




To compare differences between two experimental groups, a paired two-sample t-
test was used for analysis, except for survival data for which Kaplan-Meier 











 mice are more susceptible to pulmonary S. 
pneumoniae infection than wild-type mice 
In order to clarify the role of IL-1 on bacterial infection of the lung, both wild-type 
B6 and IL-1R
-/-
 mice were infected intratracheally with sublethal doses of S. 




 CFU). All IL-
1R
-/-
 mice died within 7 days post-infection when given 5x10
5
 CFU of WU2 strain 
while all B6 mice survived (Fig. 1A). Even the lower dose (5x10
3
 CFU) killed 
about 80% of the IL-1R
-/-
 mice (Fig. 1A). Treatment of B6 mice with anakinra, an 
IL-1 receptor antagonist, before and after infection with WU2 (5x10
5
 CFU) 
resulted in deaths in half the mice but all mice that were not treated survived (Fig. 
1B). In general, the amount of total protein in the BALF is representative of the 
severity of lung inflammation. In the kinetic study, total protein in the BALF of IL-
1R
-/-
 mice was much higher at 3 days post-infection with 5x10
5
 CFU of WU2 strain 
than found in the wild-type mice (Fig. 2A). To clarify why IL-1R
-/- 
mice are 
susceptible to S. pneumoniae infection, the level of pro-inflammatory cytokines 
were compared in BALF at 3 days post-infection in IL-1R
-/- 
and wild-type B6 mice. 
It was found that the pro-inflammatory cytokines (e.g., TNF-, IFN-, IL-6, and 
MCP-1) were significantly higher in the BALF of IL-1R
-/-
 mice than in the wild-
type B6 mice (Fig. 2B). In a histologic study, the lungs of IL-1R
-/-
 mice were not 
intrinsically different from those of B6 mice, but they had many more infiltrated 
polymorphonuclear cells and their alveolar spaces were filled with exudates at 3 
days post-infection with 5x10
5
 CFU of WU2 strain (Fig. 3). In addition, tissue 
destruction, epithelial cell layer damage, and alveolitis were much more severe in 
the IL-1R
-/-
 mice, resulting in a significantly higher clinical score than in the B6 
mice (Fig. 3). When viewed together, these results indicate that IL-1R
-/-




susceptible to sublethal intratracheal challenge with pneumococcus because of 
severe inflammation in the lung. 
 
2. Bacterial proliferation is not restrained in IL-1R
-/-
 mice 
Next, the relationship between severe inflammation and bacterial load in the       
IL-1R
-/-
 mice was assessed. There were significantly more bacteria (CFU) in the 
lungs of IL-1R
-/-
 mice at 4 hr after infection with 5x10
5
 CFU of WU2 than in the 
B6 mice; however, bacteria colonies gradually declined in the lungs of wild-type 
B6 mice by 1 day post-infection (Fig. 4A). Further, confocal microscopy at 1 day 
post-infection showed more red fluorescence-labeled WU2 strain in the lungs of 
IL-1R
-/-
 mice than in wild-type B6 mice (Fig. 4B). It was speculated that the severe 
inflammation in IL-1R
-/-
 mice might be caused by uncontrolled bacterial 
propagation. To further examine this hypothesis, two experiments to control the 
propagation of bacteria were performed. First, the IL-1R
-/-
 mice were challenged 
intratracheally with TIGR4 ΔtrpG strain, which has a defect in tryptophan G 
synthesis and therefore is invasive but cannot proliferate. IL-1R
-/-
 mice were 
infected with either the TIGR4 ΔtrpG or the mother TIGR4 strain as a control and 
determined bacterial load in the lung and survival rate. When pneumococcal 
propagation was suppressed, the IL-1R
-/-
 mice survived (Fig. 5A). Next, IL-1R
-/-
 
mice were treated with penicillin, an antibiotic for gram-positive bacteria, 6 hr after 
infection with 5x10
5
 CFU with WU2. Penicillin treatment led to total clearance of 
pneumoniae by 1 day post-infection and survival of the IL-1R
-/-
 mice (Fig. 5B). 
These results suggest that the lethal effects of pneumococcal infection in IL-1R
-/-
 







3. Normal neutrophil recruitment was detected in the IL-1-
deficient condition  
Because the role of neutrophils in the susceptibility of bacterial infection in the   
IL-1-deficient condition is controversial [62, 70], the characteristics of neutrophils 
in the lungs of IL-1R
-/-
 mice were assessed following intratracheal infection with 
5x10
5
 CFU of WU2. As shown in Fig. 6A and B, at 1 day post-infection the lungs 
of IL-1R
-/-














 neutrophils in the lungs of IL-1R
-/-
 mice than in B6 mice (Fig. 
6A and B). The level of KC, the chemokine that recruits neutrophils, in the BALF 
of B6 and IL-1R
-/-
 mice was similar at 1 day post-infection but was substantially 
enhanced in IL-1R
-/-
 mice at 3 days post-infection following intratracheal infection 
with 5x10
5
 CFU of WU2 (Fig. 6C). Moreover, the bactericidal activity of 
peritoneal neutrophils from IL-1R
-/-
 and wild-type B6 mice was similar (Fig. 7A). 
An earlier study showed that phagocytosis by alveolar macrophages also plays a 
critical role in clearing bacteria from the lung [9], therefore, the phagocytosis of 
alveolar macrophages in both B6 and IL-1R
-/-
 mice was compared at 1 day post-





macrophages captured red fluorescence-labeled WU2 strain in a normal way in 
both wild-type B6 and IL-1R
-/-
 mice (Fig. 7B). Overall, any defects were not found 
of infiltration or killing ability of neutrophils and phagocytosis of alveolar 
macrophages in IL-1R
-/-
 mice. Thus, there may be other underlying mechanisms 









4. Fibrinogen synthesis in the lung is down-regulated in the 
IL-1 signal-deficient condition  
To determine which genes are regulated by IL-1 signaling, at 4 hr after 
intratracheal infection with 5x10
5
 CFU of WU2, microarray analysis was 
conducted to assess gene expression patterns in the lungs of B6 and IL-1R
-/- 
mice 
and compared the results to those of mice given PBS. Among approximately 
50,000 genes, the SMAD signal, protein folding, and apoptosis-related genes were 
highly expressed in the lungs of IL-1R
-/-
 mice as compared with those of B6 mice 
(Fig. 8). Both Fos and Jun are transcription factors induced by TGFand SMAD 
proteins during pneumocystis pneumonia [71]. A recent study showed that 
pneumonia infection enhances endoplasmic reticulum stress and induces the 
protein folding-related genes [72]. In addition, apoptosis is a well-known feature of 
S. pneumoniae infection [73]. It was unexpectedly found that there were little 
expressions of fga and fgg mRNA in the lungs of IL-1R
-/-
, whereas mRNA 
expression of fga and fgg were significantly enhanced in the lungs of wild-type B6 
mice 4 hr after infection with WU2 (Fig. 8 and Table. 1). To confirm this result, 
quantitative PCR of fga and fgg was performed. It was found that mRNA 
expression levels of fga and fgg were greatly increased in the lungs of wild-type B6 
mice after infection but there were no significant changes in the IL-1R
-/-
 mice (Fig. 
9A). Likewise, protein levels of fibrinogen were significantly higher in BALF of 
B6 mice at 1 day post-infection than at 4 hr post infection but no changes were 
observed in the IL-1R
-/-
 mice (Fig. 9B).  On the other hand, fibrinogen levels in 
blood of both B6 and IL-1R
-/-
 mice increased in a time-dependent manner after 
infection (Fig. 9C). These results demonstrate that fibrinogen can be expressed in 
both mucosal (mainly lung) as well as systemic tissues (mainly liver) after 
pulmonary pneumococcal infection and that local synthesis of fibrinogen might be 





5. Fibrinogen synthesis is activated by IL-1- dependent IL-6 
signal 
Next, it was sought how IL-1 signal transduction induced the synthesis of 
fibrinogen in the lung after S. pneumoniae infection. Previous studies demonstrated 
that IL-6 leads to the transcription of the fibrinogen genes in lung epithelium [74] 
and that IL-6 is regulated by IL-1 receptor-mediated NFB activation [75]. 
Therefore, the IL-6 levels were examined in the BALF from wild-type and IL-1R
-/-
 
mice 4 hours after infection. The IL-6 levels were increased in both wild-type and 
IL-1R
-/-
 mice, although the amount of IL-6 in IL-1R
-/-
 mice was significantly less 
than in wild-type mice (Fig. 10A). The IL-6 signaling pathway activates Stat3, 
which acts as a transcription factor and binds to the IL-6 motif on human 
fibrinogen gamma promoter [76]. Thus, it was investigated the alteration of 
fibrinogen production by the blockade of IL-6 or Stat3 activation using anti-IL-6Ra 
Ab or Stat3 inhibitor (i.e., NSC 74859), respectively [77]. The transcriptional 
levels of fga and fgg genes were significantly reduced in wild-type mice treated 
with anti-IL-6 Ab or Stat3 inhibitor (Fig. 10B). Likewise, the fibrinogen levels in 
the BALF of wild-type mice decreased after in vivo treatment with anti-IL-6 Ab or 
Stat3 inhibitor (Fig. 11A). The reduced fibrinogen levels after treatment were 
similar to those of non-treated IL-1R
-/-
 mice at 1 day post-infection (Fig. 11A). In 
addition, the thrombin activity, which cleaves the fibrinogen to fibrin for the 
initiation of clotting, was also down-regulated in BALF of IL-1R
-/-
 mice compared 
with wild-type mice (Fig. 11B). Overall, the results clearly indicate that the 
synthesis of fibrinogen in lungs with bacterial infections is tightly regulated by the 






6. Coagulation in the lung is critical to control bacterial 
propagation 
Next, it was addressed whether the defect in the lung coagulation system, 
especially fibrinogen synthesis in the lung of IL-1R
-/-
 mice after pneumococcal 
infection, has a direct relationship to controlling bacteria. First, recombinant mouse 
fibrinogen was administered in vivo by intratracheal injection after infection with 
5x10
5
 CFU of WU2 in IL-1R
-/-
 mice and then monitored survival and bacterial 
propagation. Survival significantly improved with fibrinogen treatment (Fig. 12A), 
and at 2 days post-infection, bacterial burden in the lung had declined in the 
fibrinogen-treated IL-1R
-/-
 mice but not in those given PBS (Fig. 12A). Next, wild-
type B6 mice were orally treated with warfarin to inhibit coagulation. When 
warfarin-treated mice were infected intratracheally with 5x10
5
 CFU WU2, 
approximately 60% died within 14 days post-infection and bacterial load in the 
lung significantly increased (Fig. 12B). Overall, it was found that fibrinogen in the 
lung played an indispensable role in the control of pneumococcus in IL-1R
-/-
 mice 
and that treatment with an anti-coagulant drug exacerbated pneumococcal 






 Innate immunity is the immediate host defense against infections [8]. IL-1, 
consisting of  and subtypes, is the initial cytokine that accompanies TNF-to 
induce inflammation [78]. In the murine pneumococcal pneumonia model, high 
levels of IL-1, TNF-, and IL-6 were determined in lung exudates within 4 hr of 
infection [79, 80]. IL-1, which is mainly produced by resident alveolar 
macrophages, binds to the heterodimeric receptor made of IL-1RI and IL-1R 
accessory proteins on pulmonary epithelial cells [24, 81]. The IL-1 deficient 
condition has been presumed to be vulnerable in infectious diseases. In a previous 
study, the lack of IL-1 impaired bacterial clearance and induced high mortality in 




 mice are particularly 
susceptible to pneumococcal infection, but not IL-1
-/-
 and IL-1R antagonist
-/-
 mice 
[83]. Recently, caspase-1-independent IL-1 production but not TLR signaling was 
shown to be critical for host resistance to Mycobacterium tuberculosis or 
Chlamydia pneumoniae [84, 85]. Here was demonstrated that IL-1R
-/-
 mice have 
higher mortality and more severe inflammation than wild-type mice when infected 
i.t. with S. pneumoniae. These results suggest that IL-1 is critical for protection 
against pneumococcal infection and that deficiency of IL-1 signal gives rise to the 
weakness of the host in fighting infectious diseases. 
 In this study, IL-1R
-/-
 mice had large amounts of inflammatory cytokines in 
the BALF and predominant propagation of S. pneumoniae in the lung. The 
enhanced inflammatory responses and subsequent increased bacterial propagation 
in the IL-1-deficient condition have been reported elsewhere[82-85]. The severity 
of inflammatory responses is thought to be correlated with the uncontrolled 
proliferation of the invader. When bacterial propagation was inhibited by using the 
mutant S. pneumoniae strain or antibiotic treatment, IL-1R
-/-
 mice were rescued 




deficient condition might be caused by the breakdown of a mechanism that controls 
S. pneumoniae in the lung. 
 Neutrophils are thought to be the first innate immune cells recruited after 
infection. Within a few hours of infection, they give rise to powerful protective 
immunity, especially against extracellular bacteria [86]. The depletion of 
neutrophils after treatment with the anti-Gr-1 mAb or the blockade of neutrophil 
recruitment in the CXCR2
-/-
 mice demonstrates the failure of bacterial clearance in 
murine pneumonia models [87, 88]. Several reports have suggested that insufficient 
recruitment of neutrophils may explain the susceptibility of IL-1-deficient mice [70, 
83]. A recent study noted that IL-1 and its related signaling pathways play a 
central role in the production of CXCL8, a potent neutrophil chemoattractant, in 
rhinovirus infection [89]. However, it seems likely that IL-1R signals are activated 
via MyD88, a common adaptor molecule of TLRs, and that activation of MyD88-
mediated NFB is a general transcription factor for the induction of inflammation 
that can also be activated by TNF- [90]. Others propose that TNF- can 
compensate for IL-1-mediated NFB activation [62, 91]. There are no differences 
in the recruitment of neutrophils in the absence of IL-1 or TNF- alone, but triple-
mutant mice deficient in TNFR1, TNFR2, and IL-1RI are defective in the 
production of KC and MIP-2 and in the recruitment of neutrophils [62, 91]. In this 







recruited into the lung was similar or even higher in IL-1R
-/-
 mice than in wild-type 
mice. Further, bacterial killing ability of peritoneal neutrophils from IL-1R
-/-
 mice 
was identical to those of wild-type mice. Overall, the bactericidal ability of 
neutrophils in the IL-1R
-/-
 mice in this study seemed to operate normally. 
 Inasmuch as uncontrolled proliferation of pneumococcus cannot be fully 
explained by the recruitment and killing ability of neutrophils in the IL-1R
-/-
 mice, 
microarray analysis was used to investigate another factor that might be altered in 




coagulation factors, transcripts of fga and fgg genes, were down-regulated in lung 
tissue from IL-1R
-/-
 mice compared with wild-type mice at 4 hr after infection. 
Fibrinogen consists of two sets of three different chains (and) and is cleaved 
to fibrin by thrombin during coagulation [92]. The fibrinogen is usually 
synthesized in the liver and is abundant in circulating blood [63, 93]. However, 
previous studies indicated that constitutive expression of the three fibrinogen genes 
(fga, fgb, and fgg) were found in cultured pulmonary epithelial cells and lung 
epithelium [94, 95]. Importantly, fibrinogen can be induced in the lung epithelium 
by respiratory infection such as pneumocystis pneumonia or inflammatory 
cytokines such as IL-6 [95-97]. A recent study suggested a scenario in which 
phosphorylated Stat3, by IL-6 signaling cascade, binds to IL-6 motifs on the 
promoter region of fibrinogen genes and expresses three fibrinogen chains [98]. In 
this study, it was found less IL-6 secretion was induced in IL-1R
-/-
 mice than in 
wild-type mice at early time points after infection. This was followed by lack of 
fibrinogen in the BALF. Likewise, blockade of IL-6 or Stat3 reduced the secretion 
of fibrinogen in the lungs of infected wild-type mice. It is therefore suggested that 
IL-6 secretion induced by IL-1 signal plays an indispensable role in the synthesis 
of fibrinogen in the pulmonary epithelium against pneumococcal infection. 
 Since fibrinogen plays a key role in producing blood clots, the relationship 
between coagulation and pulmonary infection was investigated in vivo. 
Coagulation is one of the serine protease cascades and the ancestral innate immune 
system [99]. Coagulation not only contributes to arresting hemorrhage but also 
participates in controlling bacterial growth in the skin, vascular system, and liver 
[100, 101]. Moreover, when coagulation is prevented by treatment with an 
anticoagulant or as seen in fibrinogen-deficient mice, the propagation of the 
pathogen is not limited and mice have higher mortality [102]. In this study, 
thrombin activity in the BALF of infected IL-1R
-/-
 mice was reduced compared 




exogenous fibrinogen decreased the bacterial burden and delayed death. In addition, 
oral administration of warfarin dramatically decreased survival and escalated the 
bacterial burden in the lung following S. pneumoniae infection. This result supports 
the notion that coagulation plays an indispensable role in regulation of bacterial 
growth in the lung. 
 IL-1 might also regulate coagulation via neutrophil activation. 
Administration of IL-1 in baboons after lethal challenge with Escherichia coli 
induced the formation of thrombin and treatment of IL-1 receptor antagonist 
attenuated the release of neutrophil elastase [103]. A recent study revealed that 
neutrophil serine proteases promote tissue factor- and factor XII-dependent 
coagulation and help retain GAS in blood vessels [64]. Hence, it was hypothesized 
that IL-1 might have various means to regulate coagulation: These include 
induction of fibrinogen directly and activation of neutrophil serine proteases for 
enhancing thrombus formation indirectly. If so, the diminished thrombin activity in 
IL-1R
-/-
 mice could be caused by the impaired activation of neutrophil serine 
proteases but this requires further study. 
 As for application to clinical cases, IL-1R
-/-
 mice mimic humans treated 
with anakinra. Patients given anakinra or other IL-1 antagonist drugs are thought to 
be more vulnerable to infectious diseases [104]. In addition, treatment with anti-
coagulants such as warfarin also increases susceptibility to infection [101]. The 
treatment with fibrinogen ameliorates the resistance to illness.  
In summary, IL-1R
-/-
 mice are highly susceptible to pulmonary infection 
with S. pneumoniae. In this study, the bacterial burden in the lung could not be 
controlled in the IL-1-deficient condition even though the recruitment and the 






 neutrophils were normal. Of 
note, fibrinogen was synthesized locally in the lung after pneumococcal infection 
in an IL-1 signal-dependent manner and restricted the proliferation of pathogen; 




pneumonia. Taken together, these findings indicate that IL-1 might be involved in 
activating the coagulation pathway that is critical for protecting the lung against S. 










Figure 1. A. Wild-type and IL-1R
-/-
 mice of B6 background were infected 




 CFU) and monitored 
daily for survival (n=8 mice per group). B. Wild-type mice were treated 
intraperitoneally with anakinra (0.5 mg/mouse) (Amgen,  Thousand Oaks, CA), 
antagonist for IL-1, or PBS every 3 days starting 1 day before infection (dpi) with S. 
pneumoniae WU2 (5x10
5








Figure. 2. A. Total protein levels in BALF of wild-type B6 and IL-1R
-/-
 mice at 0 
and 4 hr and 1 and 3 dpi. Values are mean ± SD and results are representative of 
three independent experiments with n=5 per group. B. Proinflammatory cytokine 
levels in the BALF of wild-type and IL-1R
-/-
 mice were measured 3 days post 







Figure 3. Pathophysiologic study of the lung was done at 3 days post-infection by 
H&E staining. Representative pictures and histopathological scores are shown as 








Figure 4. A. Lung bacterial load was determined at 4 hr and 1 and 3 days after 
intratracheal challenge with S. pneumoniae WU2 strain (5x10
5
 CFU). Lung 
homogenates were serially diluted in PBS and plated onto blood agar plates to 
measure colony-forming units (CFU). B. Increased numbers of red fluorescence-
labeled WU2 in the lungs of IL-1R
-/-






Figure 5. A. Bacterial load and survival rate of IL-1R
-/-
 mice after intratracheal 
challenge with S. pneumoniae TIGR4 and its tryptophan mutant (ΔtrpG). B. Role 
of antibiotics on bacterial load and survival rate of IL-1R
-/-
 mice after intratracheal 
challenge with S. pneumoniae WU2 strain. Each mouse received 1 mg of penicillin 
6 hr after infection. CFU data are mean ± SD (n=4 mice per group) and survival 
rate (n=8 mice per group). Data are from three independent experiments. *, p<0.05; 






Figure 6. A. Cells were obtained from BALF at days 0, 1, and 3 after intratracheal 
infection with S. pneumoniae WU2 strain (5x10
5
 CFU). Cellular composition was 
determined by flow cytometry. Numbers in boxes are percentages of each cell 
population. Absolute recovered cells (B) and KC levels (C) in the BALF of wild-
type B6 and IL-1R
-/-
 mice are shown before and after infection. Data represent 






Figure 7. A. No significant difference was found between wild-type B6 and        
IL-1R
-/-
 mice in neutrophil killing ability in vitro. Numbers of bacteria are shown 
as mean ± SEM (n=4 mice per group). *, p<0.05; ***, p<0.001. B. Wild-type B6 
and IL-1R
-/-
 mice were infected with 5x10
5
 CFU of PKH-labeled or non-labeled S. 
pneumoniae WU2. Phagocytosis in the cells in BALF was analyzed by flow 
cytometry 1 day after infection. Numbers indicate percentages of gated cells. 







Figure 8. Total RNA of the whole lung tissue was extracted and gene expression 
profiles were addressed by microarray analysis. Wild-type B6 and IL-1R
-/-
 mice 
were infected intratracheally with S. pneumoniae WU2 strain (5x10
5
 CFU). Lung 
tissue samples were taken at 0 and 4 hr after infection. Data are representative of 






Figure 9. A. Quantitative PCR for mRNA levels of fibrinogen alpha (Fga) and 
gamma (Fgg) in the lung was done to confirm the microarray analysis results. The 
mRNA expression levels were adjusted to the expression levels of -actin. Values 
are mean + SD of three independent experiments carried out in triplicate. B. The 
protein level of fibrinogen was determined by ELISA in BALF at 0 and 4 hr and 1 
day after infection. C. The level of fibrinogen in peripheral blood was determined 
by ELISA at days 0, 1 and 3 after infection with S. pneumoniae WU2 (5x10
5
 CFU). 
Results are representative of three independent experiments. *, p<0.05; **, p<0.01. 









Figure 10. A. IL-6 levels in BALF from wild-type or IL-1R
-/-
 mice were measured 
by ELISA at 0 and 4 hr after infection with S. pneumoniae WU2 (5x10
5
 CFU). B. 
Wild-type B6 mice were treated intratracheally with PBS, anti-IL-6 Ab (0.1 
mg/mouse), or Stat3 inhibitor (NSC 74859; 10 g/mouse) following infection. 
Quantitative PCR was used to determine mRNA levels of fibrinogen alpha (Fga) 
and gamma (Fgg) in the lung 4 hr after infection. The mRNA expression levels 
were adjusted to the expression levels of -actin. Values are mean + SD of three 
independent experiments carried out in triplicate. Data are representative of three 








Figure 11. A. Fibrinogen levels measured in BALF by ELISA at days 0 and 1 day 
post-infection. Significance is versus 1 day post-infection. Data are representative 
of three independent experiments. B. Thrombin activity in BALF at 0 and 1 day 
post-infection. Values are mean relative fluorescence units (RFU) + SED of five 
mice per group. Data are representative of three independent experiments.              









Figure 12. A. Survival plots of IL-1R
-/-
 mice treated intratracheally with PBS or 
mouse fibrinogen (Fib.; 0.1 mg/mouse) at days 0 and 1 post-infection with S. 
pneumoniae WU2 (5x10
5
 CFU). Lung bacterial load was determined at 2 days 
post-infection (n=8 per group). Graphs for bacterial CFU are shown as mean ± SD 
(n=4 per group). Data are representative of three independent experiments. B. 
Survival plots for wild-type B6 mice treated intragastrically with PBS or warfarin 
(10 g/mouse) every day from 1 day before infection with WU2 (5x10
5
 CFU). 
Lung bacterial load was determined at 5 days post-infection (n=9 per group). 
Graphs for bacterial CFU are shown as mean ± SD (n=4 per group). Data are 







Figure 13. Graphic summary. Streptococcus pneumoniae infection induces the 
production of IL-and cytokines which bind to IL-1 receptors. IL-1 signals 
through its adaptor molecule, MyD88, to activate NFB. The activated NFB is 
translocated in nucleus and expresses proinflammtory genes such as IL-6. The 
secreted IL-6 signals to Stat3 in pulmonary epithelia. The activated Stat3 moves 
into nucleus and binds on the promoter of fibrinogen gene. The produced 
fibrinogen acts as a source of coagulation. The enhanced coagulation inhibits the 






Table 1. Differentially expressed genes in WT versus IL-1R
-/-
 (|FC| ≥ 2)  
SD, standard deviation; P, adjusted p-value; FC, fold change; Statistical 














Expansion of Tfh-like cells during chronic 
Salmonella exposure mediates the 
generation of autoimmune hypergamma-












Bacterial persistence leads to polyclonal B-cell proliferation and 
hypergammaglobulinemia [105]. Although the mechanism underlying nonspecific 
B-cell activation in chronic infection is uncertain, possible explanations include 
direct activation by B-cell mitogens and bystander activation by cytokines from 
helper T cells [105-107]. In several studies using MyD88
-/- 
mice, the activation of 
B cells through Toll-like receptor (TLRs) is regarded as a key factor [105]. 
Furthermore, MyD88 signaling in innate cells may contribute to autoantibody 
production in B cell-activating factor of the tumor necrosis factor family (BAFF) 
transgenic mice [108]. Also, T cell-independent activation of autoreactive B cells is 
known to be elicited in a MyD88-dependent manner [109]. However, another 
recent study found that mice deficient in MyD88 still elicit 
hypergammaglobulinemia and autoantibody production after chronic infection by 
Borrelia burgdorferi [110], suggesting there might be other stimulators for B-cell 
activation in chronic bacterial infection.   
Although B cells can be activated in a T cell-independent manner, T cells 
provide a milieu for efficient B-cell proliferation, somatic hypermutation, and 
class-switch recombination of immunoglobulin [111, 112]. Follicular helper T (Tfh) 
cells, which were recently characterized as a new subset of CD4
+
 helper T cells, are 
now regarded as critical for the regulation of humoral responses, including the 
germinal center (GC) reaction [39, 40]. Tfh cells express ICOS, CD40L, PD-1, and 
CXCR5 on the cell surface, but their function has not been fully elucidated. ICOS-
ICOSL interaction, IL-21 and IL-6, but not IL-4, IFN-, and TGF-β, are important 
for the generation of Tfh cells, suggesting that Tfh cells are a distinct subset of 
CD4
+
 helper T cells, independent of Th1, Th2, and Th17 cells [39, 40, 113]. 
Further, PD-1 expressed on Tfh was recently found to be important for the survival 




In this study, it was sought whether MyD88-dependent TLR signals are 
required for the generation of B cell responses in the course of Salmonella 
infection at the late chronic stage. Unexpectedly, MyD88
-/-
 mice given oral 
recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain exhibited 
autoimmune hypergammaglobulinemia with an enhanced GC reaction; however, 
wild-type mice had no significant changes. Further, it was found that the enhanced 
B-cell responses in the MyD88-deficient condition was directly due to the aberrant 






















 myeloid cells accumulated adjacent to CD4
+
 T cells. Collectively, 
the enhanced generation and activation of Tfh-like cells triggered 
hypergammaglobulinemia with autoimmunity in the MyD88-deficient condition 




II. Materials and Methods 
 
1. Mice  
Wild-type BALB/c and C57BL/6 (B6) mice were purchased from Charles River 
Laboratories (Orient Bio Inc., Korea). MyD88
-/-
 mice were kindly provided by 
Shizuo Akira (Research Institute for Microbial Diseases, Osaka Univ., Osaka, 
Japan). All mice used in the experiments were between 6 and 12 weeks of age. 
Mice were maintained under pathogen-free conditions in the experimental facility 
at the IVI (Seoul, Korea), where they received sterilized food and water ad libitum. 
The experiments were approved by the Institutional Animal Care and Use 
Committee of the IVI. 
 
2. Bacteria strain 
Recombinant attenuated Salmonella vaccine strain (RASV), S. Typhimurium 
χ9241 [ΔpabA1516 ΔpabB232 ΔasdA16 ΔaraBAD23 ΔrelA198:: araCPBADlacI 
(ATG)TT, containing pYA3620] (RASV), was used in this study [65, 114]. The 
strain was grown at 37℃  in Luria-Bertani broth without shaking. The actual 
administered bacterial dose was confirmed by plating serial dilutions onto 
MacConkey agar plates (Becton Dickinson, Sparks, MD).  
 
3. Ab for flow cytometric analysis 
All Abs were from BD Biosciences (San Jose, CA) except for anti-OX40L 







4. Cytokine detection 
BD™ CBA (Cyto ine Bead Assay) Mouse Inf ammation  it and Th1/Th2/Th17  it 
(BD Biosciences) were used to assess the amount of cytokines in the serum. The 
splenocyte was restimulated with PMA (50 ng/ml) and ionomycin (750 ng/ml) in 
the medium containing BD Go giStop™ for 4 hr in vitro. Mu tico or staining for 
surface Ags and intracellular IL-21  as performed by BD Cytofix/Cytoperm™ 
according to the manufacturer’s protoco . 
  
5. ELISA 
NUNC-Immuno MaxiSorp p ates (NUNC, Denmar )  ere coated  ith 2 μg/m  
goat F(ab’)2 anti-mouse Ig-UNLB, human adsorbed (Southern Biotechnology 
Associates, Birmingham, AL) in 50 mM sodium bicarbonate and incubated 
overnight at 4℃ as described elsewhere [115]. After blocking with 1% BSA in 
PBS, 100 μ / e   serum seria  di utions or standard di utions in 1% BSA in PBS 
were added to the plates for 2 hr at 37℃. HRP-conjugated goat anti-mouse IgG, 
IgA, and IgM Abs (Southern Biotechnology Associates) (1:3000 anti-mouse 
immunoglobulin Ab except for IgM (1:10000) in 0.1% BSA in PBS plus 0.1% 
Tween 20) was added to each well at 37℃. For color development, the substrate 
solution (TMB; Moss, Pasadena, MD) was added. Color development was stopped 
by adding 0.5 N HCl and measured at 450 nm on an ELISA reader (Microplate 
spectrophotometer; Molecular Devices, Sunnyvale, CA).  
 
6. Anti-double-stranded DNA assay 
Anti–double-stranded (ds) DNA Ab were detected using NUNC-Immuno 
MaxiSorp plates (NUNC A/S). Plates were coated overnight at 4℃, first with 100 
g/ml methylated BSA (Calbiochem, San Diego, CA) and then with 50 g/ml of 




sheared by sonication, and finally digested with S1 nuclease. After blocking, serial 
dilutions of the serum samples were added and incubated at room temperature for 2 
hr. Autoantibodies were detected with goat anti–mouse IgG-HRP (Sigma) and 
developed as previously described [116].  
 
7. Neutralizing Ab treatment  
Anti-CD4 Ab purified from GK1.5 hybridoma (ATCC, Rockville, MD) was used 
for depletion of CD4
+
 T ce  s (200 μg/mouse). Purified anti-ICOS Ab and anti-PD-
1 Ab from eBioscience were injected i.p. for the neutralization of ICOS and PD-1 
on CD4
+
 T ce  s, respective y. Mice  ere injected i.p.  ith 200 μg of Ab or isotype 
control rat IgG (Sigma) Ab 1 day before vaccination and every 3 or 4 days 
thereafter.  
 
8. Histopathological analysis 
For the IgG and IgA staining, kidneys were fixed in 4% paraformaldehyde and 
embedded in paraffin. Tissues were cut into 5-μm sections and stained with anti-
mouse-IgG-HRP and anti-mouse-IgA-HRP. The peroxidase activity was 
determined using DAB substrate kit (Vector Labs, Burlingame, CA). The sections 
were mounted and viewed under x20 optics using a digital light microscope. For 
the immunohistochemical study, freshly obtained spleens were rapidly frozen in 
OCT embedding medium (Tissue-Tek, Sakura Finetek, Japan) after sucrose 
gradient dehydration procedures and stored at -80˚C unti  processing. Cryostat 
sections (  μm)  ere fixed in cold acetone (-20˚C). Tissues  ere stained  ith PE-
conjugated CD4, PE- or FITC-conjugated B220 (all BD Pharmingen) and biotin-
conjugated peanut agglutinin (PNA) (Vector Labs) and then visualized with Alexa 
Fluor
®
 488-conjugated streptavidin (Molecular Probes, Eugene, OR). The sections 
were mounted with PermaFluor mounting medium (Thermo, Cheshire, UK) and 





9. Real-Time RT-PCR 
Total splenocytes were obtained from Balb/c background MyD88
-/-
 mice 4 weeks 
after infection with RASV. Total RNA was isolated from CD4
+
 T cells sorted by 
MACS (Miltenyi Biotec, Bergisch Gladbach, Germany). Reverse transcription was 
performed using SuperScript™ II Reverse Transcriptase (Invitrogen) according to 
the manufacturer’s instructions. For rea -time PCR analysis, the cDNA was serially 
diluted 10-fold and amplified using the 7500 Real Time PCR System (Applied 
Biosystems) with Power SYBR
®
 Green PCR Master Mix (Applied Biosystems). 
After the first denaturation step (95°C for 10 min), amplification was performed for 
40 cycles at 95°C for 15 s, 55°C for 15 s, and 72°C for 40 s. The final cycle was 
followed by the dissociation stage. The following primers were used for RT-PCR: 
T-bet:  ’-CCT GGA CCC AAC TGT CAA CT-3’ (for ard) and  ’-AAC TGT 
GTT CCC GAG GTG TC-3’ (reverse); GATA3:  ’-CTG GAG GAG GAA CGC 
TAA TG-3’ (for ard) and  ’-CAG GGA TGA CAT GTG TCT GG-3’ (reverse); 
BCL-6:  ’-CTG CAG ATG GAG CAT GTT GT-3’ (for ard) and  ’-CAC CCG 
GGA GTA TTT CTC AG-3’ (reverse); IL-21: 5'-GAG GAC CCT TGT CTG TCT 
GG-3’ (for ard) and  '-TCA CAG GAA GGG CAT TTA GC-3' (reverse); and 
CXCR :  ’-CGA CAT CAG ACA GTG ACC AGC C-3’ (for ard) and  ’-GTC 
CTG TAG GGG AAT CTC CGT G-3’ (reverse) [117, 118]. 
 
10. Isolation of myeloid cells 
Splenocytes were prepared from RASV-infected MyD88
-/-
 mice and Gr-1-positive 
cells were isolated using biotinylated anti-Gr-1 Ab (RB6-8C5) and anti-biotin 
microbeads (Miltenyi Biotec). The purity of Gr-1
+
 cells was more than 90% in total 
viable cells and most of the Gr-1
+





11. In vitro T cell suppression 
OT-II CD4
+
 T cells (5×10
5
/well) were stimulated with OVA (grade V; Sigma)-




 cells from 
MyD88
-/-
 mice administered RASV. For the fina  24 hr, 1 μCi/ e   of 
3
H-
thymidine  as added and cu tured ce  s  ere harvested by Fi terMate™ Ce   
Harvester (PerkinElmer
®
, Downers Grove, IL). 
3
H-thymidine incorporation into 
divided cells was detected by using MicroBeta
®
 TriLux (Wallac, Turku, Finland). 
 
12. Data and statistical analysis 
The Student’s t-test was used to compare differences between two experimental 
groups. To compare multiple groups, one-way ANOVA was carried out followed 
by the Tukey-HSD post hoc test. Each experiment was repeated three times. P 
























1. Persistent Salmonella exposure in MyD88
-/-
 mice results in 
systemic inflammation with autoimmune hypergamma-
globulinemia 
It was previously found that TLR signaling via MyD88 is not essential for 





 cells to  mice led to significant defects of antigen-specific Ab 
production after oral administration with recombinant attenuated Salmonella 
Typhimurium vaccine (RASV) strains [115]. In the current study, it was attempted 
to determine which factors contribute to B cell responses in MyD88
-/-
 mice given 
the attenuated vaccine strain RASV χ9241 (ΔpabA ΔpabB ΔasdA) strain that has 
been used extensively as a multivalent vector expressing heterologous antigens. 
RASV is able to invade and transiently persist in lymphoid tissues including 
Peyer's patches, spleen, and liver. It stimulates immune responses but causes no 
disease symptoms in wild-type mice. Unexpectedly, in this study, oral 
administration of RASV provoked significantly increased total IgG and IgA levels 
in the sera of MyD88
-/-
 mice as compared with levels found in wild-type mice of 
BALB/c and B6 background (Fig.1A and B); however, IgM levels were similar in 
both wild-type and MyD88
-/-
 mice after RASV administration (Fig. 1A). In 
addition to the increase of total IgG in the sera of MyD88
-/-
 mice, Salmonella-
specific IgG Ab were also elevated (Fig. 2A). These data are supported by the 
findings in the previous studies in which anti-LPS or anti-PspA specific Ab was 
determined [65, 115]. Next, it was investigated whether the 
hypergammaglobulinemia in MyD88
-/-
 mice after RASV administration, especially 
with increased serum IgG levels, could be related to autoimmunity. Surprisingly, 
anti-dsDNA autoantibodies were detected in sera obtained from MyD88
-/-




weeks after oral RASV challenge (Fig. 2B). Moreover, the deposition of immune 
complex was observed in kidneys of RASV-administered MyD88
-/-
 mice (Fig. 2C). 
In addition, MyD88
-/-
 mice had increased levels of serum pro-inflammatory 
cytokines including IL-6, TNF-, MCP-1, and IFN- but not IL-4 and IL-5 at 2 
weeks after oral RASV challenge (Fig. 3A). Further, significant numbers of 
Salmonella were found persisting in polymorphonuclear cells of MyD88
-/-
 mice, 
but not in wild-type mice, at 4 weeks after oral administration of RASV (Fig. 3B). 
These findings suggest that MyD88
-/-
 mice failed to eradicate Salmonella even 
though the production of inflammatory cytokines and Salmonella-specific Ab was 
elevated. Taken together, MyD88
-/-
 mice orally infected with attenuated Salmonella 
showed autoimmune hyper-IgG responses with systemic inflammation in the 
chronic stage. 
 
2. Expansion of B cell compartment is accompanied by 
augmentation of CD4
+




 myeloid cells 
In accordance with hyper-IgG responses, MyD88
-/-
 mice administered oral 
RASV had en arged sp eens, mesenteric and cervica   ymph nodes, and Peyer’s 
patches (Fig. 4A). Of interest, total recovered CD4
+




inflammatory myeloid cells, as well as CD19
+
 B cells were significantly increased 
in spleens of MyD88
-/-
 mice compared with wild-type mice after oral RASV 
challenge (Fig. 4B). Previous studies suggested that GC formation was delayed 
until 1 month after attenuated Salmonella infection in wild-type mice [119, 120]. 
Further, extrafollicular Ab responses to attenuated Salmonella were IL-21-
independent [119, 120], whereas GC B cell responses were regulated by IL-21 
produced by T cells [121]. In the present study with MyD88
-/-
 mice, however, 
significantly increased GC formation in MyD88
-/-
 mice was found than in wild-
type mice 4 weeks after oral RASV challenge (Fig. 5A and B). A previous study 










staining was used to further confirm the acceleration of GC formation in MyD88
-/-
 
mice following oral RASV administration. Expanded CD19
+ 
B cells in the spleens 
of RASV-administered MyD88
-/-
 mice significantly co-expressed high levels of 
GL7 on their surfaces unlike those of wild-type mice (Fig. 5C and Fig. 6). These 
finding suggest that B cells are highly proliferative and generate GC under the 
MyD88-deficient condition caused by chronic Salmonella infection. To clarify the 
cross-talk among the expanded cell populations in RASV-administered MyD88
-/-
 
mice, the distribution of each cell population in the spleen was determined by 
immunofluorescence confocal microscopy. Two-color staining of spleen sections 
of RASV-administered MyD88
-/- 
mice produced overviews of cell population 
locations in which extrafollicular CD4
+
 T cells (red) were adjacent to Gr-1
+
 cells 
(green) (Fig. 7A). Further, some CD4
+
 T cells (red) were located in the B cell 
follicles (green) (Fig. 7B). These results suggest the possibility of cross-talk 
between CD4
+




 inflammatory myeloid cells as well as the 
activation of B cells by CD4
+
 T cells inside the B cell follicles.  
 
3. Hypergammaglobulinemia is CD4
+
 T cell-dependent and 
Tfh-like cells accumulate in MyD88
-/-
 mice after RASV 
challenge 
Since the role of CD4
+
 T cells was important for efficient B cell response, 
the need for CD4
+
 T cells for hypergammaglobulinemia was assessed by depleting 
CD4
+
 T cells with anti-CD4 mAb in groups of mice orally administered RASV. In 
both wild-type and MyD88
-/-
 mice, the depletion of CD4
+
 T cells completely 
blocked the generation of polyclonal IgG Ab in sera after oral RASV challenge 
(Fig. 8A). Since the induction of several cell surface molecules on CD4
+
 T cells 
have been suggested to be closely related to hypergammaglobulinemia [123], the 
expression of PD-1, CD62L, GITR, and CD25 on splenic CD4
+




determined after RASV challenge. It was found that the expression of PD-1 was 
drastically increased in the splenic CD4
+
 T cells of MyD88
-/-
 mice compared with 





 T cells were addressed using other Tfh cell markers 
including CXCR5, ICOS, OX40, and CD127 [39, 40].  It was found that more than 




 cells expressed ICOS and OX40 and lost CD127 expression, 
a well-known phenotype for Tfh cells [39, 40, 124]. In addition, 14.3(±2.5)% of 
CD4
+
 T cells from MyD88
-/-
 mice had the phenotypes of Tfh cells, expressing both 
CXCR5 and PD-1, compared with only 3.1(±1.1)% of CD4+ T cells from wild-





T cells expressed CXCR5 as did more than 55% of ICOS
+





T cells in the spleens of RASV-infected MyD88
-/-
 mice (Fig. 9A). 
ICOS expression was assessed in splenic CD4
+
 T cells before and after RASV 




 T cells in 
RASV-administered MyD88
-/-





 T cells at the steady-state condition (Fig. 9B). The ICOS expression 
on splenic CD4
+
 T cells of MyD88
-/-
 mice increased 2 weeks after RASV 
administration (Fig. 9C), which correlated with the increased kinetics of serum IgG 




 cells from RASV-
infected MyD88
-/-
 mice produced IL-21; however, MyD88
-/-
 mice had more IL-21-
secreting cells than the RASV-infected wild-type mice (Fig. 10A). Further the 
RASV-administered MyD88
-/-
 mice had significantly increased transcriptional 
levels of bcl-6, IL-21, and CXCR5, but not of t-bet and gata-3 (Fig. 10B), 
suggesting the transcriptional patterns of Tfh cells [31]. Of note, many ICOS
+
 cells 
(stained red) were located inside the B cell follicles (green) in MyD88
-/-
 mice after 
oral RASV challenge (Fig. 10C). Overall, these data suggest that the induction of 
hypergammaglobulinemia was CD4
+
 T cell-dependent and that Tfh-like cells, 




















), were highly accumulated in MyD88
-/-
 mice after 
RASV administration. 
 




 inflammatory myeloid 
cells accumulated in MyD88
-/-
 mice after oral RASV 
challenge 




 myeloid cells, which were 
dramatically expanded in MyD88
-/-
 mice after RASV administration (Fig. 4B and 




 cells could be ascribable to the increased 
levels of serum GM-CSF [125] in the MyD88
-/-
 mice after RASV administration, 
which occurred in a time-dependent manner (Fig. 11B). Analysis of the cell surface 




cells in both wild-type and MyD88
-/-
 
mice highly expressed MHC class II, CD40, CD80, and CD86 together with low 
expression of CD11c on their surfaces after oral RASV challenge (Fig. 12). They 
also expressed PD-L1 and ICOS-L, suggesting possible cross-signaling between 









 cells in the spleens of MyD88
-/-
 mice after oral RASV administration 























cells in particular expressed CD40, CD80, and CD86 but had low expression of 




 cells isolated from 
RASV-administered wild-type and MyD88
-/-
 mice were the main cell population 
producing high levels of IL-6 after restimulation with RASV in vitro (Fig. 14). 
This finding might be important for B cell activation by inducing Tfh-like cells. 





inflammatory myeloid cells in MyD88
-/-
 mice could influence CD4
+




regulate Tfh-like cell differentiation after RASV challenge in the chronic 
inflammatory condition. 
 
5. Blockade of CD4
+
 Tfh-like cells by anti-ICOS or anti-PD-1 
Ab treatment ameliorates the induction of 




Next, to assess whether the expanded CD4
+
 Tfh-like cells could induce B 
cell class switching to IgG, the function of CD4
+
 Tfh-like cells was blocked by 
anti-ICOS or anti-PD-1 Ab treatment in MyD88
-/-
 mice after oral RASV 
administration and checked to see if they could prevent the induction of 
hypergammaglobulinemia in chronic inflammation caused by persistent Salmonella 
infection. It was found that blockade of ICOS costimulation reduced the increment 
of total serum IgG production in the MyD88
-/-
 mice (Fig. 15A). In addition, 
blocking of PD-1 signaling significantly reduced the induction of 
hypergammaglobulinemia in the MyD88
-/-
 mice (Fig. 15B). The blockade of ICOS 
or PD-1 signaling also decreased anti-dsDNA specific autoantibodies in the RASV-
administered MyD88
-/-
 mice (Fig. 15C). Taken together, ICOS- and PD-1-
expressing Tfh-like cells, which expand in MyD88
-/-
 mice after chronic Salmonella 
infection, are crucial for aberrant induction of serum IgG Ab and the blockade of 
ICOS and PD-1 ameliorate the induction of autoimmune hypergammaglobulinemia 




IV. Discussion  
Although the activation of autoreactive B cells during infection has long 
been considered to result from non-specific bystander activation of polyclonal B 
cells, the mechanisms of hypergammaglobulinemia in the infected host remain 
uncertain [106]. Chronic infection with B. burgdorferi in self-reactive B cell 
transgenic mice breaks the immunologically ignorant status of autoreactive B cells 
and causes hypergammaglobulinemia in a CD4
+
 T cell-dependent manner, in which 
in vitro B cell proliferation against B. burgdorferi is completely dependent on 
MyD88-mediated TLR signaling [105]. In contrast, MyD88
-/-
 mice show 
significant B cell hyperplasia accompanying autoantibody production and 
hypergamma-globulinemia in the same B. burgdorferi infection model [110]. Thus, 
the suppressive role of MyD88 on B cells has been proposed as a control 
mechanism against autoreactive B cell activation. Similarly, MyD88 has been 
postulated to provide a negative signal for Th2 cell development via TLR signaling 
in dendritic cells [127, 128]. However, in a model of polymicrobial sepsis, the 




 cells in the spleen mediated Th2 
cell-dependent hyper-B cell responses [129]. Thus, the role of MyD88-dependent 
innate signaling for the regulation of B cell responses in the inflammatory 




 myeloid cells. 
In this regard, it was previously shown that in mice vaccinated with attenuated 
Salmonella, MyD88 is not essential for generation of antigen-specific B cell 




 cells to  mice led to 
significant defects of antigen-specific Ab production after oral vaccination with 
attenuated Salmonella strains, suggesting that there might be other stimulators for 
B cell activation in MyD88
-/-
 mice chronically infected with bacteria [115]. In the 
present study, persistent Salmonella infection resulted in the generation of Tfh-like 




During analysis of expanded cell populations in RASV-administered 
MyD88
-/-




 T cells was detected, 
which resembled Tfh cells, and typically express PD-1, CXCR5, BCL-6, and IL-21 
[39, 40]. Tfh cells are a subset of activated CD4
+
 T cells and are specialized to 
regulate B cell-mediated humoral immunity [113, 130]. Furthermore, a recent 
study suggested that persistent infection of virus could drive the differentiation of 
helper T cells to Tfh cells [131]. Although Tfh cells are linked to GC B cell 
survival and the formation of long-lived plasma cells [43, 132], their role in 
chronic inflammatory condition, especially related to persistent bacteria, has not 
been reported.  
ICOS has been considered an inducible T cell costimulatory molecule 
important for CD40-mediated Ab class switching [133]; however, recent studies of 
uncontrolled expression of ICOS in several gene-modified mice showing lupus-like 
pathology provide insight for the close relationship between ICOS-expressing 
CD4
+
 T cells and autoimmunity [123, 134]. In the present study, blockade of ICOS 
using neutralizing Ab significantly reduced the production of total IgG in RASV-
administered MyD88
-/-
 mice, suggesting possible cross-talk between Tfh-like cells 
and B cells via ICOS-ICOSL interaction for hypergammaglobulinemia.  
The results of current study suggest that extra-follicular helper T cells 
assist in the production of autoantibodies in an IL-21-dependent manner similar to 
Tfh cells, but that they do not express CXCR5 and that they are located outside the 
B cell follicles [123]. Further, dysregulation of Tfh cells or extrafollicular helper T 
cells has been linked with development of autoimmunity in several murine models 







 T cells expanded in RASV-administered MyD88
-/-
 mice were 
found to be a mixed population of both Tfh cells (CXCR5
+
) and extrafollicular 
helper T cells (CXCR5
-
) (Fig. 9A). Thus, it is possible that both Tfh and 




PD-1 is a well-known marker for CD8
+
 T cell exhaustion [137] and 
recently the blockade of PD-1 has been reported to enhance Ab production in 
response to helminth infection [138]. However, PD-1 was also found to be 
involved in GC B cell survival and formation of long-lived plasma cells [43]. PD-1 
was blocked using anti-PD-1 Ab in RASV-infected MyD88
-/-
 mice, thereby 
ameliorating the induction of hypergammaglobulinemia in those mice. When these 
findings are considered together, the persistent presence of attenuated Salmonella 
strain might trigger CD4
+
 T cell differentiation into intra- and extrafollicular helper 




Interestingly, a recent study showed that CTLA4-Ig, a promising 
treatment for rheumatoid arthritis, significantly reduced the upregulation of PD-1 
and ICOS on Tfh cells in a murine model of arthritis [135, 139], providing 
evidence for the relationship between abnormal Tfh cell activation and 
autoimmunity. Further, CTLA4-Ig treatment reduced GC B cell responses and 
prevented breach of B cell tolerance [135], suggesting that CD28-dependent 
signaling is also required for optimal Tfh cell generation and that regulation of Tfh 
cell generation is important to prevent the onset of autoimmunity including 
autoantibody production. 
To determine the specific factors in RASV-infected MyD88
-/-
 mice 
responsible for Tfh-like cell generation, cells neighboring CD4
+
 T cells in the 
spleen were analyzed. Findings of co-localization of CD4
+
 T cells and Gr-1
+
 cells 
in spleens of RASV-administered MyD88
-/-





 inflammatory myeloid cells might regulate the generation of CD4
+
 




 inflammatory myeloid cells produced IL-6, 
one candidate cytokine for Tfh cell differentiation [140, 141], and also expressed 
ICOSL and PD-L1. However, the requirement of IL-6 for Tfh cell development in 
vivo is still controversial [141], and IL-6 might influence B cell activation T cell-




 inflammatory myeloid 
 
 64 
cells may modulate Tfh-like cells in the chronic inflammatory condition. 
Previously, the expansion of myeloid-derived suppressor cells (i.e., MDSCs) was 
reported in mice infected with aroA mutant and wild-type Salmonella and these 
MDSCs inhibited antigen-specific CD4
+





 inflammatory myeloid cells obtained from RASV-infected MyD88
-/-
 
mice showed suppression against OT-II CD4
+
 cell proliferation when there were 
equivalent numbers of myeloid cells and CD4
+
 T cells (Fig. 16). However, 
proliferation of OT-II CD4
+





cells declined, suggesting the divergent regulation of CD4
+





 myeloid cells under different conditions. In addition, although the 
accumulation of Gr-1
+
 myeloid cells with high titers of Salmonella-specific Ab was 
previously reported in mice, there was no significant alteration in splenic CD4
+
 T 
cells [143]. Thus, the role of MyD88 for the protection of aberrant CD4
+
 T cell 











cells, which have the characteristics of activated macrophages, could be the 
candidate for Tfh cells differentiation in chronic infection. They highly expressed 
MHC class II molecules and costimulatory molecules such as CD40, CD80, and 





 inflammatory myeloid cells was unsuccessful (data not 
shown). Further studies will be needed to elucidate the mechanism for the 
differentiation of the Tfh-like cells in the persistent exposure of attenuated 
Salmonella. Another possibility for uncontrolled B cell activation in MyD88
-/-
 mice 
after RASV infection is failure in the feedback regulation of Tfh cell generation 
and function by plasma cells. Recently, plasma cells were reported to regulate Tfh 
cells in an antigen-specific manner and mice deficient in plasma cells showed lack 
of negative feedback regulation for Tfh cell activity [144, 145].  
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Collectively, systemic hyper-IgG Ab response to persistent bacterial 
exposure might be initiated as a danger signal to provoke immune responses but 
fail to control the infection due to the lack of proper defense by the MyD88 
molecule. This could result in chronic inflammation and possibly autoimmunity. 
Depletion of CD4
+
 T cells as well as blockade of PD-1 and ICOS in Tfh-like cells 
prevents aberrant increases of total serum IgG, suggesting that Tfh-like cells 
expanded in chronic bacterial infection can be considered as targets for the 

















Figure 1. A. Sera from BALB/c and MyD88
-/-
 mice were analyzed for IgM, IgG, 
and IgA levels 4 weeks after oral administration of RASV (1x10
9
 cfu). Data are 
shown as mean +SD of n=4-8 mice per group. B. Serum IgG Ab at weeks 0, 2, and 
4 after oral RASV administration in both BALB/c and B6-background wild-type 
and MyD88
-/-






Figure 2. A. Reciprocal titration of anti-Salmonella specific IgG Ab in serum at 0 
and 4 weeks after RASV administration in wild-type and MyD88
-/-
 mice.  Lysate of 
RASV strain were prepared by freezing and thawing the harvested cells in the lysis 
buffer (50 mM Tris-HCl (pH 8.0), 1 mM DTT, 0.1% Triton X-100, and protease 
inhibitor) followed by sonication. Supernatant was then coated for ELISA (n=4 or 
5 mice/group). *p<0.05, **p<0.01, ***p<0.001 (Student t-test). B. Anti-dsDNA-
specific serum IgG Ab were analyzed by ELISA 4 weeks after BALB/c and 
MyD88
-/-
 mice were orally administered RASV. Data are shown as mean ± SD of 
n=4 mice per group. *p<0.05 and **p<0.01, ANOVA. C. Kidney sections of 
BALB/c and MyD88
-/-
 mice 4 weeks after oral RASV administration stained with 





Figure 3. A. Serum cytokine levels including TNF-, MCP-1, IFN-, IL-4, IL-5, 
and IL-6 at 2 weeks after RASV cha  enge (n=  mice/group). *p<0.0 , Student’s t-
test. B. Intracellular survival of RASV strain as determined by PMN isolated from 
mesenteric lymph node (MLN) and spleens of wild-type and MyD88
-/-
 mice of 
BALB/c background 4 weeks after oral administration of RASV (10
9
 cfu/head). 
CFU were counted using Salmonella-Shigella agar containing 0.05% arabinose and 
0.1% mannose. n.d., not detectable. Data are representative of three independent 





Figure 4. A. Wild-type and MyD88
-/-
 mice were orally administered 1x10
9
 cfu of 
RASV on day 0 and sacrificed at weeks 2 and 4 (5 mice/group). A. Enlarged 
sp eens (a), mesenteric  ymph nodes (b), Peyer’s patches (c), and inguina   ymph 
nodes (d) in MyD88
-/-
 mice (bottom) compared with wild-type mice (top) 4 weeks 
after RASV challenge. Data are representative of five experiments. B. Kinetic 
analysis of absolute numbers of CD4
+
 T cells, CD19
+





myeloid cells in the spleens of wild-type and MyD88
-/-
 mice 2 and 4 weeks after 
RASV challenge. Data are shown as mean ± SD of n=4-5. *p<0.05, **p<0.01, 








Figure 5. A. Immunofluorescent analysis of spleen sections before and 4 weeks 
after RASV challenge. Expression patterns of peanut agglutinin (PNA, green) and 
B220 (red) are shown. Scale bar: 100 m. B. Number of PNA
+
 germinal centers 
counted in the histologic sections. Data are shown as mean + SD of six 
independent experiments. C. Flow cytometric analysis of GL7-expressing B cells 
and statistics for GC B cells. Data are shown as mean + SEM of n=3-4 samples 











Figure 6. Expression levels of GL7 on CD19
+
 B cells 4 weeks after oral 





were  analyzed by FACS to assess GL7 expression, and the percentages of 
GL7-expressing B cells among total CD19
+








Figure 7. A. Two-color staining with Gr-1
 +
 cells (green) and  CD4
+
 T cells (red) in 
spleens of MyD88
-/-
 mice after oral RASV administration. Scale bar: 50 mm. Data 
are representative of two independent experiments with at least three mice per 
group.  B. Immunofluorescent analysis of spleen sections from MyD88
-/-
 mice at    
4 weeks following oral RASV administration. Expression patterns of B220 (green) 
and CD4 (red) are shown. Scale bar: 20 m. Data are representative of five 






Figure 8. A. Wild-type and MyD88
-/-
 mice were treated with anti-CD4-depleting 
Ab by i.p. injection at 3-day intervals beginning 1 day before oral RASV 
administration. Four weeks later, sera were obtained and analyzed for total IgG Ab. 
Data are shown as mean + SD of n=5 mice from one experiment representative of 
two. *p<0.05 versus control Ab-injected mice, Student’s t-test. B. Expression 
levels of PD-1, CD62L, GITR, and CD25 on splenic CD4
+
 T cells in wild-type 
(WT) and MyD88
-/-
 mice 4 weeks after oral administration of RASV. Data are 








Figure 9. A. Co-expression of Tfh cell markers CXCR5, ICOS, OX40, and CD127 
Ab on PD-1-expressing CD4
+
 T cells was analyzed on splenocytes from WT or 
MyD88
-/-
 mice 4 weeks after oral RASV administration. Ratios of each negative 
and positive population among PD-1
+
 cell populations are shown in upper left and 
upper right of each quadrant. Data are representative of three experiments (n=3 
mice/group). B. Flow cytometric analysis of ICOS expression on CD4
+
 T cells 
from spleens of WT and MyD88
-/-
 mice before and 4 weeks after oral RASV 
administration. Data are representative of five experiments. C. Kinetic analysis of 
ICOS
+
 cells among splenic CD4
+
 T cells at 0, 2, and 4 weeks after oral RASV 








 cells analyzed by flow cytometry 
after restimulation with PMA and ionomycin in vitro. The ratio on top of the dot 






 cells in CD4
+
 cells (n=3 
mice/group). B. Relative expression levels of T-bet, Gata-3, Bcl-6, IL-21, and 
CXCR5 mRNA isolated from splenic CD4
+
 T cells of BALB/c or MyD88
-/-
 mice 4 
weeks after RASV administration analyzed by real-time PCR. Data are mean +SD 
(n=4) after normalization to -actin levels. C. Immunohistochemical analyses of 
spleen sections of BALB/c and MyD88
-/-
 mice. Green; B220, Red; ICOS. Scale bar: 
50 mm (left and middle) and 10 mm (right). Data are representative of three 
independent experiments. Number of ICOS
+
 cells in indicated areas counted in 








 cells in splenocytes after flow 
cytometry analysis. Data are shown as mean + SEM of n=2-5 mice/group (right) 
and are representative of five independent experiments. B. GM-CSF levels in the 
serum of wild-type or MyD88
-/- 
mice of BALB/c background were determined by 
ELISA kit (BD Biosciences, San Diego, CA) at 2 or 4 weeks after oral RASV 










 gated cells 
from WT and MyD88
-/-
 mice as determined by flow cytometry analysis (gray filled 
histogram: isotype control). Median fluorescence intensities (MFIs) of gated cells 
from WT and MyD88
-/-
 mice are indicated at tops of histograms. Data are 








Figure 13. Splenic cell populations in BALB/c and MyD88
-/-





























 cells, FACS analysis results of surface expression of 
the indicated molecules on the gated cells. Median fluorescence intensities of gated 
cells from isotype control (gray) and each specific Ab (bold). Data are 









 cells in spleens of WT 
(blue bars) and MyD88
-/-
 mice (red bars). MyD88
-/-
 mice were infected with         
10 MOI of RASV in vitro for 4 hr before ELISA analysis of IL-6 in supernatant. 
Data are shown as mean + SD of n=3-5 mice/group and are representative of three 
independent experiments. **p<0.01 and ***p<0.001 compared with BALB/c-






Figure 15. A. MyD88
-/-
 mice (B6 background) were treated i.p. with anti-ICOS Ab 
(200 g/mouse) at 3-day intervals beginning 1 day before oral RASV 
administration (1×10
9
 cfu/mouse). Four weeks later, sera were analyzed for total 
IgG. Data are shown as mean of n=5-6 mice/group. B. MyD88
-/-
 mice (B6 
background) were treated i.p. with anti-PD-1 Ab (200 g/mouse) at 3-day intervals 
beginning 1 day before oral RASV administration (1×10
9
 cfu/mouse). Four weeks 
later, sera were analyzed for total IgG. Data are shown as mean of n=6-9 
mice/group. C. Titers of anti-dsDNA-specific IgG Ab in serum were measured by 
ELISA. Data are shown as mean of n=8 mice/group. **p<0.01; ***p<0.001 versus 
MyD88
-/-






Figure 16. OVA-specific CD4
+
 T cells from OT-II mice were stimulated with 





 cells isolated from RASV-administered MyD88
-/-
 mice. Detection of 
[
3
H]thymidine incorporation in divided cells. Data are representative of three 











Figure 17. Graphic summary. In normal condition, various TLR ligands such as 
LPS activate dendritic cells (DC) by the infection of salmonella. The activated DC 
presenting salmonella antigens differentiates naïve CD4
+
 T cells into effector T 
cells which help the B cell function. In contrast, DC activation may be reduced and 
normal T and B cell activation also decreases in MyD88-deficient condition. In 
MyD88
-/-





myeloid cells which can produce IL-6. IL-6 rich environment related to the 
generation of Tfh. Increased Tfh cells activate B cells which produce antibodies 









In the overall study, the role of innate signals induced by IL-1 and MyD88 
were examined in two different bacteria infection models. One was the pulmonary 
infection of pneumococcus and the other was the systemic infection of the 
attenuated salmonella strain which was administered orally. These two studies 
were focused on innate and adaptive immune responses, respectively. However, 
they could be combined in the IL-1R/TLR superfamily and bacterial infection.   
The chapter I is entitled “IL-1 promotes coagulation which is necessary for 
protective immunity in the lung against S. pneumoniae infection”.  The coagulation 
was proposed as an innate immune response in the respiratory tract. IL-1 was 
discovered as a fever producer over 60 years ago [146]. The researches about IL-1 
were considered as an old-fashioned subject because new cytokines were 
discovered continuously. However, IL-1 was given attention once again when the 
focus shifted to finding inflammasome which is important mechanism to produce 
the active form of IL-1 and IL-18. The study of IL-1 is complicated because it is a 
very initiative signal and links to various secondary responses. Bacterial 
proliferation was not controlled in IL-1 deficient condition. Some reports insisted 
that the recruitment of neutrophils was defective in IL-1R
-/-
 mice. But others 
claimed the neutrophil trafficking was regulated by several signals and was able to 
be compensated by other signals [62, 70]. This argument might be influenced by 
time points after infection, methods to isolate and to count cells and stain of 
pathogens. In this study, several methods and various time points were employed to 







neutrophils in the bronchial alveolar lavage fluid (BALF) migrated normally in IL-
1R
-/-
 mice at 1 day after the infection. At 3 day post-infection (dpi), more 
neutrophils were detected in IL-1R
-/-
 mice because of more bacterial burden even 
though the possibility of the immune regulatory function of IL-1 was concerned. In 
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contrast, neutrophils were less detected within 1 dpi in the cytospin of BALF from 
IL-1R
-/-
 mice than wild-type mice (data are not shown). Overall, IL-1 influences 
the recruitment of neutrophils for which other signals can compensate at early time 
after infection. IL-1 may impact on the maturation of neutrophils in the tissue to 
shape the characteristic morphology of nuclei segmentation. 
Blood clotting was unexpectedly found as an immune system for pulmonary 
infection with bacteria. The participation of coagulation in bacterial pneumonia is a 
unique report in the immunology. Coagulation is highly conserved in vertebrate so 
that the animal and human might conduct the coagulation pathway for controlling 
bacterial proliferation although some pathogens also have the escaping properties 
from clotting for the virulency. In this study, exogenous fibrinogen was treated in 
vivo to recover the deficiency of IL-1R
-/-
 mice. The treatment was obviously 
effective but the survival was delayed only one day. The reason of the insufficient 
rescue of IL-1R
-/-
 mice is the reduced thrombin activity of IL-1R
-/-
 mice. The 
providing of both active thrombin and fibrinogen can be more effective but the 
intratracheal administration in the C57BL/6 mice is difficult because of the small 
capacity of lung compared with BALB/c mice. In addition, the coagulation can 
occur between treated thrombin and fibrinogen without bacteria trapping. 
Therefore, the coagulation factors regulated by IL-1 signals in the upstream of 
thrombin should be identified to develop more efficient treatment for coagulation. 
The bacteria killing mechanism of coagulation is not fully elucidated yet. The 
elevated level of fibrinogen in the lung after the infection is approximately one 
thousandth less than that of the fibrinogen in the blood. In addition, the clots were 
hardly observed in the histological study. However, the corelationship between 
coagulation pathway and bacterial propagation in the lung is evident based on the 
data in this study. Coagulation can be initiated in the pathogen-specific manner by 
binding to the surface of bacteria [49]. Coagulation pathway is also linked to 
complement pathway [99]. Moreover, neutrophils are involved in the activation of 
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coagulation [64]. Therefore, the complicated relation of coagulation pathway with 
other compartments manipulates the regulation of bacteria. 
The chapter II is entitled “Expansion of Tfh-like cells during chronic 
Salmonella exposure mediates the generation of autoimmune hypergamma-
globulinemia in MyD88-deficient mice”. The RASV-administered MyD88
-/-
 mice 
demonstrated chronic salmonellosis and hypergammaglobulinemia. MyD88 
molecule is markedly important to the innate signals. However, MyD88-
independent innate signals also exist, for example, TRIF-dependent TLR3 signal. 
The induction of hyperIgG syndrome in MyD88
-/-
 mice administered with RASV 
seems to be associated with chronic infection rather than MyD88-deficient signals. 
Since, MyD88
-/-
 mice showed more severe inflammation than wild-type mice. 
Furthermore, there is a report in which the chronic infection of virus induces the 
differentiation of Tfh [131]. Hence, RASV-administered MyD88
-/-
 mice are 
proposed as a chronic infection model of salmonella Typhimurium. 
In this study, the detail mechanism for the generation of Tfh is not fully 




 cells can be a candidate to 




 cells express MHC II, PD-L1 and ICOSL and 
secrete IL-6 after stimulation of salmonella. Also, these cells are located and 
contact with CD4
+









 cells can induce the activation of 
the expression of ICOS in naïve CD4
+










 cells are concerned with myeloid-derived suppressor cells (MDSC) 










 cells should be explained. 
The role of innate signal in the pathogenic infection was studied. IL-1 
encourages a coagulation pathway to restrict the multiplication of pneumococci in 
the low respiratory tract. The chronic salmonellosis in RASV-administered 
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MyD88-deficient condition generates the accumulation of Tfh cells in spleen. The 
increased Tfh cells modulate the production of autoantibody and the induction of 
hypergammaglobulinemia. Overall, the innate signals through IL-1 and MyD88 
have not only a pivotal role in restraining bacteria but also in the induction of 
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병원성 세균 감염 시 방어면역을 위한 









모든 생명체는 다양한 병원균의 침입에 대한 방어기제로 면역체계를 
가지고 있다. 이 면역체계를 발동시키기 위해서는 먼저 개체 자신과 
구별하여 병원체들만이 특이적으로 가지고 있는 분자 패턴을 인지하기 
위한 수용체들이 필요하다. 이러한 수용체들 중 대표적인 것으로 
인터류킨 1 수용체/ 톨유사 수용체 슈퍼패밀리가 있다. 이 수용체들은 
다양한 병원균들의 감염에 대해 면역반응을 유도하는 초기 신호체계이다. 
본 연구에서는 병원성 세균의 감염에 있어서 개체가 가진 선천성 면역 
신호들의 역할을 규명하고자 한다. 
 본 논문의 첫번째 부분에서는, 세균감염시 TNF-와 함께 선천성 
면역반응을 유도하는 것으로 잘 알려진 인터류킨 1 (IL-1)에 대해 
연구하였다. IL-1은 알려진 시간에 비해 호흡기 감염에 있어서 그 기작이 
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충분히 밝혀지지 않았다. 따라서 본 연구에서는 마우스 모델에서 폐렴균 
(Streptococcus pneumoniae) 감염시 인터류킨 1 의 신호가 어떻게 
개체의 방어기제에 작용하는 지를 연구하였다. 인터류킨 1 수용체 결손 
마우스 (IL-1R-/-)는 폐렴균의 감염시 높은 사망률을 보이며, 동시에 
폐부에서 대량의 사이토카인의 분비와 침습물이 관찰된다. 또한 
인터류킨 1의 신호가 결손되었을때 폐부에서 세균의 분열이 억제되지 않는 
것이 관찰되었다. 하지만 이러한 세균의 확산이 억제되지 않는 것이 
CD11b+Ly6C+Ly6G+ 한 호중구의 유입이나 살균작용이 정상인 
마우스보다 결핍되어 일어나는 현상은 아니었다. 놀랍게도 폐렴균 감염시 
인터류킨 1 수용체 결손마우스에서 정상 마우스에서는 감염후 증가하는 
피브리노겐 알파와 감마의 전사가 저하되어 있는 것을 발견하였다. 
피브리노겐은 혈액응고의 중요한 인자로서 피브리노겐의 합성이 
인터류킨 1, 인터류킨 6, Stat 3의 신호전달 체계에 의존적이라는 결과를 
얻었다.  또한 인터류킨 1 수용체 결손마우스에서 피브리노겐을 
투여하였을때 생존율과 세균의 증식이 억제되었고, 정상 마우스에서 
혈액응고를 억제하는 약물을 투여하였을 때에 폐렴균 감염에 대한 
감수성이 증가하는 것을 확인하였다. 이러한 결과를 토대로 인터류킨 1의 
신호가 폐렴균 감염시 폐조직 내에서 혈액응고에 관여하는 피브리노겐의 
합성을 증가시키고 이를 통해서 폐렴균의 증식을 억제할 수 있다는 결론을 
도출하였다. 
본 논문의 두번째 부분으로, 만성 살모넬라균 감염시 Myeloid 
Differentiation factor 88 (MyD88)에 의존적인 톨유사 수용체의 
신호가 B 세포 반응의 생성에 어떠한 역할을 하는 지에 관해 연구하였다. 
MyD88 결손 마우스에 약독화한 살모넬라 백신균주 (Recombinant 
attenuated Salmonella Typhimurium vaccine; RASV)를 
구강투여하였을 때에 감염의 만성화가 나타났다. 그 결과로 germinal 
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center 가 증가하고, 혈액 내에 항 이중나선 DNA 에 특이적인 항체를 
포함하는 고감마글로불린혈증이 관찰되었다. 또한 자가면역질환의 
특징으로 나타나는 신장에 면역복합체의 침착이 관찰되었다. 만성 
감염화된 마우스에서는 PD-1, CXCR5, ICOS, IL-21 을 발현하는 
CD4 양성인 T 세포가 특히 증가하였고, 이러한 T 세포의 증식은 
Follicular helper T (Tfh)와 유사한 특징을 가지고 있다. T 세포를 
결핍시켰을때에는 혈액 내에 다클론성 항체의 생성이 완전히 억제되었다. 
RASV 를 구강투여한 MyD88 결손 마우스의 또 다른 특징으로는 
비장에서 많은 양의 CD11b 와 Gr-1 을 발현하는 염증성 골수세포가 
축적되었음을 관찰하였다. 흥미롭게도 PD-1 이나 ICOS 의 신호를 
방해하였을때에 고감마글로불린혈증과 항이중나선 DNA 에 대한 항체가 
감소하였음을 확인하였다. 따라서 만성 살모넬라균의 감염시 PD-1 과 
ICOS 에 의존적으로 Tfh 유사 세포의 작용에 의해 자가면역성의 
고감마글로불린혈증이 나타나는 것으로 결론지을 수 있다.  
 
주요어: 인터류킨 1, 폐렴균, 폐렴, 선천면역,  혈액응고, MyD88, 살모넬라, 
Tfh, 적응면역, 만성감염, 자가항체, 고감마글로불린혈증 
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